Related Experiment Video
Updated: Sep 9, 2025

09:07
Analyzing the Functions of Mast Cells In Vivo Using 'Mast Cell Knock-in' Mice
Published on: May 27, 2015
10.5K
Probing the Code of Chronic Urticaria Pathogenesis: How the ceRNA Network Regulates Mast Cell Activation
Zezhi He1,2, Jiazhen Chen1,2, Hui Wu1,2
1Institute of Dermatology,Guangzhou Medical University, Guangzhou, China.
International Archives of Allergy and Immunology
|August 28, 2025
Summary
The competitive endogenous RNA (ceRNA) network drives chronic urticaria (CU) via hierarchical mast cell activation. Targeting ceRNA pathways offers potential precision therapies for refractory CU.
Area of Science:
- Immunodermatology
- Molecular Biology
- RNA Biology
Background:
- Chronic Urticaria (CU) involves mast cell (MC) activation, with many patients unresponsive to current treatments.
- The competitive endogenous RNA (ceRNA) network is implicated in MC signaling, but its regulatory hierarchy is unclear.
Purpose of the Study:
- To analyze the ceRNA network's role in sustained MC activation in CU.
- To propose a three-tiered regulatory model for ceRNA networks in CU.
- To evaluate ceRNA-targeting strategies for precision therapy in CU.
Main Methods:
- Systematic literature review of PubMed/Web of Science (2000-2024).
- Keywords: "chronic urticaria", "ceRNA", "lncRNA", "circRNA", "mast cell".
- Integration of ceRNA mechanisms and pathway analysis with schematic representations.
Main Results:
- The ceRNA network exhibits three hierarchical regulatory levels.
- Level 1: Core RNAs (e.g., NEAT1) sequester microRNAs (miRNAs), affecting signaling pathways.
- Level 2: Shared miRNAs (e.g., miR-155) link upstream and downstream targets.
- Level 3: Effector molecules (e.g., STAT3) mediate mast cell activation.
Conclusions:
- The ceRNA network is crucial for sustained mast cell activation in chronic urticaria.
- A three-tiered regulatory model elucidates ceRNA network function.
- RNA therapeutics and exosome delivery targeting ceRNA axes present novel strategies for refractory CU.
Related Concept Videos
Asthma: Pathogenesis and Management
576
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
576
Asthma-II: Pathophysiology and Classification
2.8K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.8K
Inflammation
55.1K
Overview
55.1K
Allergic Reactions
28.5K
Overview
28.5K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
451
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
451
T Cell Types and Functions
1.4K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.4K

